25.17
Viking Therapeutics Inc (VKTX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
19.21%
132.60
|
164.12 | 164.74 | 98.56 | 74.57 |
| Operating Income/Loss |
19.21%
-132.60
|
-164.12 | -164.74 | -98.56 | -74.57 |
| Net Income/Loss |
19.14%
-128.02
|
-158.32 | -157.66 | -90.79 | -65.56 |
| Basic Average Shares |
0.60%
116.26
|
115.57 | 0.45 | 112.32 | 112.13 |
| Diluted Average Shares |
0.60%
116.26
|
115.57 | 0.45 | 112.32 | 112.13 |
| Basic Earnings Per Share |
19.71%
-1.10
|
-1.37 | -1.39 | -0.81 | -0.58 |
| Diluted Earnings Per Share |
19.71%
-1.10
|
-1.37 | -1.39 | -0.81 | -0.58 |
大文字化:
|
ボリューム (24 時間):